Variable response of plasma GH in acromegalic patients treated with medroxyprogesterone acetate.
Malarkey
W B
WB
Daughaday
W H
WH
D001695:Biology; D001769:Blood; D019411:Clinical Laboratory Techniques; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003933:Diagnosis; D004703:Endocrine System; D005193:Family Planning Services; D005947:Glucose; D005951:Glucose Tolerance Test; D006728:Hormones; D007267:Injections; D017258:Medroxyprogesterone Acetate; D010827:Physiology; D010902:Pituitary Gland; D010907:Pituitary Hormones
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D006728:Hormones; D010907:Pituitary Hormones; D017258:Medroxyprogesterone Acetate; D005947:Glucose
Biology; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Contraceptive Agents--therapeutic use; Endocrine System; Examinations And Diagnoses; Family Planning; Glucose Metabolism Effects; Glucose Tolerance Test; Hematological Effects; Hemic System; Hormones; Injectables; Laboratory Examinations And Diagnoses; Laboratory Procedures; Medroxyprogesterone Acetate--administraction and dosage; Medroxyprogesterone Acetate--side effects; Medroxyprogesterone Acetate--therapeutic use; Physiology; Pituitary Gland; Pituitary Hormones--analysis; Protein Bound Iodine Alterations